CIK 0001867096 · Large accelerated filer
Xeris Biopharma Holdings, Inc.
Sign in to watch- Ticker
- XERS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 871082097
- Phone
- 844-445-5704
- Business address
- 1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,678,894
- in 11 filings, $1.7M under 10b5-1 plans
Net −$1,678,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-10-05 | JOHNSON JOHN Director | Grant or award · Stock Option (Right to Buy) | +31,360 | 31,360 | ||
| 2021-10-05 | JOHNSON JOHN Director | Grant or award · Stock Option (Right to Buy) | +215,600 | 215,600 | ||
| 2021-10-05 | JOHNSON JOHN Director | Grant or award · Stock Option (Right to Buy) | +68,600 | 68,600 | ||
| 2021-10-05 | HALKUFF DAWN Director | Grant or award · Stock Option (Right to Buy) | +19,650 | 19,650 | ||
| 2021-10-05 | HALKUFF DAWN Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2021-10-05 | HALKUFF DAWN Director | Grant or award · Stock Option (Right to Buy) | +11,228 | 11,228 | ||
| 2021-10-05 | HALKUFF DAWN Director | Grant or award · Stock Option (Right to Buy) | +11,228 | 11,228 | ||
| 2021-10-05 | BORMANN-KENNEDY BARBARA-JEAN ANNE Director | Grant or award · Stock Option (Right to Buy) | +19,650 | 19,650 | ||
| 2021-10-05 | BORMANN-KENNEDY BARBARA-JEAN ANNE Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2021-10-05 | BORMANN-KENNEDY BARBARA-JEAN ANNE Director | Grant or award · Stock Option (Right to Buy) | +11,228 | 11,228 | ||
| 2021-10-05 | BORMANN-KENNEDY BARBARA-JEAN ANNE Director | Grant or award · Stock Option (Right to Buy) | +11,228 | 11,228 | ||
| 2021-10-05 | Edick Paul R See Remarks | Grant or award | +197,231 | 197,231 | ||
| 2021-10-05 | Edick Paul R See Remarks | Grant or award | +410,833 | 608,064 | ||
| 2021-10-05 | Edick Paul R See Remarks | Grant or award | +13,430 | 13,430 | ||
| 2021-10-05 | Edick Paul R See Remarks | Grant or award · Stock Option (Right to Buy) | +668,065 | 668,065 | ||
| 2021-10-05 | Edick Paul R See Remarks | Grant or award · Stock Option (Right to Buy) | +69,822 | 69,822 | ||
| 2021-10-05 | Edick Paul R See Remarks | Grant or award · Stock Option (Right to Buy) | +98,252 | 98,252 | ||
| 2021-10-05 | Edick Paul R See Remarks | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2021-10-05 | Edick Paul R See Remarks | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2021-10-05 | Shannon John Patrick Jr See Remarks | Grant or award | +70,496 | 70,496 |
Page 15 of 18 · 354 trades